专题：Amyloidosis: Diagnosis, Treatment, Outcomes

This cluster of papers focuses on the molecular mechanisms, diagnosis, treatment, and prognosis of amyloidosis, with a particular emphasis on transthyretin-related cardiac and familial amyloid polyneuropathy. It covers topics such as RNAi therapy, cardiovascular magnetic resonance, and immunoglobulin light chain involvement.
最新文献
Charting the future of AL amyloidosis: Diagnostic advancements, prognostic insights, and therapeutic challenges

review Full Text OpenAlex

Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial

article Full Text OpenAlex

Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B

article Full Text OpenAlex

Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy

article Full Text OpenAlex

Transthyretin amyloid cardiomyopathy: Evolving therapies, expanding hope

review Full Text OpenAlex

T-Amylo Score for the Diagnosis of Transthyretin Cardiac Amyloidosis in Patients With Acute Heart Failure

article Full Text OpenAlex

Progressive Demyelinating Disease Associated with Adalimumab Treatment in a Patient Diagnosed with Ankylosing Spondylitis

article Full Text OpenAlex

Analysing the role of ultraviolet A1 phototherapy in the treatment of primary cutaneous lichen amyloidosis in a patient with skin phototype 1

article Full Text OpenAlex

Usefulness of STREI: A new index of right heart function in patients with immunoglobulin light chain cardiac amyloidosis

article Full Text OpenAlex

Therapeutic Role of Venous Leg Compression in Worsening Heart Failure With Predominant Extravascular Congestion: A Case Report

article Full Text OpenAlex

近5年高被引文献
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

article Full Text OpenAlex 1266 FWCI85.617

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

article Full Text OpenAlex 879 FWCI56.585

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

article Full Text OpenAlex 533 FWCI60.353

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

article Full Text OpenAlex 490 FWCI31.912

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

article Full Text OpenAlex 351 FWCI53.99

Performance of plasma phosphorylated tau 181 and 217 in the community

article Full Text OpenAlex 330 FWCI61.442

The expanding amyloid family: Structure, stability, function, and pathogenesis

review Full Text OpenAlex 301 FWCI8.789

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

article Full Text OpenAlex 285 FWCI18.913

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

article Full Text OpenAlex 259 FWCI25.031

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

article Full Text OpenAlex 259 FWCI25.031